Get the Stockscreener App
3.68
1.10%
0.04
Cardio Diagnostics Holdings Inc stock is traded at $3.68, with a volume of 19,901.
It is up +1.10% in the last 24 hours and down -17.67% over the past month.
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
See More
Previous Close:
$3.64
Open:
$3.62
24h Volume:
19,901
Relative Volume:
0.40
Market Cap:
$6.40M
Revenue:
-
Net Income/Loss:
$-9.37M
P/E Ratio:
-4.0444
EPS:
-0.9099
Net Cash Flow:
$-7.34M
1W Performance:
+1.38%
1M Performance:
-17.67%
6M Performance:
-75.69%
1Y Performance:
-70.83%
1-Day Range:
$3.61
$3.74
1-Week Range:
$3.25
$4.00
52-Week Range:
$3.22
$53.10
Cardio Diagnostics Holdings Inc Stock (CDIO) Company Profile
Name
Cardio Diagnostics Holdings Inc
Sector
Industry
Phone
855-226-9991
Address
311 W. SUPERIOR STREET, CHICAGO
Compare CDIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDIO
Cardio Diagnostics Holdings Inc
|
3.68 | 6.47M | 0 | -9.37M | -7.34M | -0.9099 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Cardio Diagnostics Holdings Inc Stock (CDIO) Latest News
Short interest data insights for Cardio Diagnostics Holdings Inc.Quarterly Performance Summary & Fast Momentum Entry Tips - Newser
Cardio Diagnostics Holdings Inc. stock momentum explainedEarnings Growth Report & Expert Verified Movement Alerts - Newser
Ranking Cardio Diagnostics Holdings Inc. Equity Warrant among high performing stocks via toolsEarnings Risk Summary & Precise Entry and Exit Recommendations - Newser
What data driven models say about Cardio Diagnostics Holdings Inc.’s futureRate Hike & Fast Gaining Stock Reports - Newser
Will Cardio Diagnostics Holdings Inc. outperform the market2025 Performance Recap & Advanced Technical Analysis Signals - Newser
Best data tools to analyze Cardio Diagnostics Holdings Inc. stockMarket Risk Report & Free Reliable Trade Execution Plans - Newser
How high can Cardio Diagnostics Holdings Inc. stock goWeekly Volume Report & Free Community Consensus Stock Picks - Newser
Market reaction to Cardio Diagnostics Holdings Inc.’s recent newsJuly 2025 Decliners & Fast Exit and Entry Strategy Plans - Newser
How sentiment analysis helps forecast Cardio Diagnostics Holdings Inc. Equity WarrantJuly 2025 Highlights & Verified Short-Term Plans - Newser
Cardio Diagnostics Holdings Inc. Equity Warrant’s volatility index tracking explainedJuly 2025 News Drivers & Daily Growth Stock Tips - beatles.ru
Will a bounce in Cardio Diagnostics Holdings Inc. offer an exitQuarterly Performance Summary & Verified Stock Trade Ideas - Newser
Using AI based signals to follow Cardio Diagnostics Holdings Inc. Equity Warrant2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - Newser
What to expect from Cardio Diagnostics Holdings Inc. Equity Warrant in the next 30 daysJuly 2025 Macro Moves & Capital Protection Trading Alerts - Newser
What earnings revisions data tells us about Cardio Diagnostics Holdings Inc. Equity WarrantPortfolio Value Report & Fast Moving Stock Trade Plans - Newser
Analyzing net buyer seller activity in Cardio Diagnostics Holdings Inc.Share Buyback & Detailed Earnings Play Alerts - Newser
Evaluating Cardio Diagnostics Holdings Inc. with trendline analysis2025 AllTime Highs & High Conviction Trade Alerts - Newser
Analyzing Cardio Diagnostics Holdings Inc. with risk reward ratio chartsJuly 2025 Decliners & Fast Exit Strategy with Risk Control - Newser
Can momentum traders help lift Cardio Diagnostics Holdings Inc.2025 Dividend Review & Free Expert Verified Stock Movement Alerts - Newser
Price momentum metrics for Cardio Diagnostics Holdings Inc. Equity Warrant explained2025 Major Catalysts & Verified High Yield Trade Plans - Newser
Institutional scanner results for Cardio Diagnostics Holdings Inc.Market Growth Summary & Weekly Top Gainers Trade List - Newser
Statistical indicators supporting Cardio Diagnostics Holdings Inc. Equity Warrant’s strengthJuly 2025 Recap & Free Technical Pattern Based Buy Signals - Newser
Will Cardio Diagnostics Holdings Inc. Equity Warrant price bounce be sustainableJuly 2025 WrapUp & Long-Term Safe Return Strategies - Newser
Backtesting results for Cardio Diagnostics Holdings Inc. trading strategiesJuly 2025 Analyst Calls & Verified Stock Trade Ideas - Newser
Statistical indicators supporting Cardio Diagnostics Holdings Inc.’s strengthGold Moves & Real-Time Chart Breakout Alerts - Newser
Developing predictive dashboards with Cardio Diagnostics Holdings Inc. Equity Warrant dataJuly 2025 Setups & Entry and Exit Point Strategies - Newser
Real time scanner hits for Cardio Diagnostics Holdings Inc. explainedWeekly Market Outlook & Daily Volume Surge Trade Alerts - Newser
How institutional ownership impacts Cardio Diagnostics Holdings Inc. Equity Warrant stockMarket Movement Recap & Safe Entry Zone Identification - Newser
Will breakout in Cardio Diagnostics Holdings Inc. lead to full recoveryPortfolio Performance Summary & Weekly High Return Stock Opportunities - Newser
Cardio Diagnostics Holdings Inc. recovery potential after sell offDividend Hike & Safe Capital Growth Plans - Newser
Will Cardio Diagnostics Holdings Inc. Equity Warrant outperform the marketTrade Signal Summary & Expert Verified Stock Movement Alerts - Newser
Cardio Diagnostics Holdings Inc. Inches Toward Key Resistance — Will It BreakMarket Trend Report & Verified Chart Pattern Signals - kangso.co.kr
Cardio Diagnostics Holdings Second Quarter 2025 Earnings: US$0.97 loss per share (vs US$1.71 loss in 2Q 2024) - Yahoo Finance
Can trapped investors hope for a rebound in Cardio Diagnostics Holdings Inc.July 2025 Final Week & Accurate Buy Signal Alerts - Newser
Cardio Diagnostics Holdings Inc Stock (CDIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cardio Diagnostics Holdings Inc Stock (CDIO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dogan Meeshanthini | Chief Technology Officer |
Sep 06 '24 |
Buy |
0.29 |
68,965 |
20,000 |
197,310 |
| Dogan Meeshanthini | Chief Executive Officer |
Sep 06 '24 |
Buy |
0.29 |
68,965 |
20,000 |
1,683,867 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):